Corsevin M
Alternative Names: 12D-10Fab; CVS-12D10Latest Information Update: 11 Jun 2000
At a glance
- Originator Unknown
- Class Anticoagulants; Antithrombotics; Monoclonal antibodies
- Mechanism of Action Factor VIIa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arterial thrombosis; Disseminated intravascular coagulation; Unstable angina pectoris
Most Recent Events
- 11 Jun 2000 Discontinued-II for Arterial thrombosis in USA (IV-injection)
- 11 Jun 2000 Discontinued-II for Disseminated intravascular coagulation in USA (IV-injection)
- 11 Jun 2000 Discontinued-II for Unstable angina pectoris in USA (IV-injection)